{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T11:09:21Z","timestamp":1758280161912,"version":"3.40.3"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23H02957\/JP23K27648"],"award-info":[{"award-number":["JP23H02957\/JP23K27648"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22H03506\/JP23K24763"],"award-info":[{"award-number":["JP22H03506\/JP23K24763"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020963","name":"Moonshot Research and Development Program","doi-asserted-by":"publisher","award":["JPMJMS2021"],"award-info":[{"award-number":["JPMJMS2021"]}],"id":[{"id":"10.13039\/501100020963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJSP2145"],"award-info":[{"award-number":["JPMJSP2145"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJSP2145"],"award-info":[{"award-number":["JPMJSP2145"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJFS2115"],"award-info":[{"award-number":["JPMJFS2115"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Bromocriptine, generally regarded as a dopamine D2 receptor agonist, has been used to treat patients with type 2 diabetes in the USA; however, its mechanisms of action including the receptors that mediate its anti-diabetic effects remain unclear. Therefore, we herein conducted pharmacological and genetic knockout experiments to investigate how bromocriptine improves glucose metabolism under type 2 diabetic conditions. Bromocriptine transiently increased blood glucose levels in both wild-type and dopamine D2 receptor-deficient mice. This glucose-elevating effect was blocked by the \u03b12-adrenergic receptor antagonist yohimbine. On the other hand, when bromocriptine was administered daily for two weeks, glucose tolerance improved in wild-type mice fed a high-fat diet. Similar anti-diabetic effects of bromocriptine were observed in dopamine D2 receptor-deficient, dopamine D1 receptor-deficient, and orexin-deficient mice under the diet-induced obese condition as well as in genetically obese <jats:italic>db\/db<\/jats:italic> mice. Bromocriptine-induced improvements in glucose tolerance were not affected by a pretreatment with the autonomic ganglion blocker hexamethonium, which suggested the involvement of the peripheral effects of bromocriptine. Given the biphasic properties of bromocriptine, we examined the drug effect on hepatic endoplasmic reticulum (ER) stress that dually regulates glucose metabolism. In the livers of diet-induced obese mice, the levels of ER stress markers, including C\/EBP homologous protein (CHOP), were reduced by the daily administration of bromocriptine. In human hepatoma HepG2 cells, increases in CHOP expression by thapsigargin, a potent inducer of ER stress, were prevented by a pretreatment with low concentrations of bromocriptine, whereas high concentrations induced CHOP expression. These results suggest that low concentrations of bromocriptine caused beneficial ER stress preconditioning, which protected against subsequent severe ER stress in the liver. Therefore, bromocriptine may prevent obesity-induced glucose intolerance via peripheral mechanisms including promotion of hepatic ER homeostasis, but not central dopamine D2 receptor-mediated mechanisms.<\/jats:p>","DOI":"10.1371\/journal.pone.0320157","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T19:55:02Z","timestamp":1743018902000},"page":"e0320157","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bromocriptine improves glucose tolerance in obese mice via central dopamine D2 receptor-independent mechanism"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8723-1711","authenticated-orcid":true,"given":"Hiroshi","family":"Tsuneki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Takatsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satsuki","family":"Masui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuta","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7358-4022","authenticated-orcid":true,"given":"Masashi","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5819-8556","authenticated-orcid":true,"given":"Tsutomu","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyasu","family":"Sasaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"issue":"4","key":"pone.0320157.ref001","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2337\/dc11-0064","article-title":"Bromocriptine: a sympatholytic, D2-dopamine agonist for the treatment of type 2 diabetes","volume":"34","author":"RA Defronzo","year":"2011","journal-title":"Diabetes Care"},{"issue":"9786","key":"pone.0320157.ref002","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0140-6736(11)60207-9","article-title":"Management of type 2 diabetes: new and future developments in treatment","volume":"378","author":"AA Tahrani","year":"2011","journal-title":"Lancet"},{"issue":"11","key":"pone.0320157.ref003","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1055\/s-0035-1559684","article-title":"Efficacy and safety of bromocriptine-QR in type 2 diabetes: a systematic review and meta-analysis","volume":"47","author":"W Liang","year":"2015","journal-title":"Horm Metab Res"},{"issue":"17","key":"pone.0320157.ref004","doi-asserted-by":"crossref","first-page":"13255","DOI":"10.3390\/ijms241713255","article-title":"Brain dopamine-clock interactions regulate cardiometabolic physiology: mechanisms of the observed cardioprotective effects of circadian-timed bromocriptine-QR therapy in type 2 diabetes subjects","volume":"24","author":"AH Cincotta","year":"2023","journal-title":"Int J Mol Sci"},{"key":"pone.0320157.ref005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2015.12.029","article-title":"Dopaminergic drugs in type 2 diabetes and glucose homeostasis","volume":"109","author":"F Lopez Vicchi","year":"2016","journal-title":"Pharmacol Res"},{"issue":"1","key":"pone.0320157.ref006","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.pcd.2015.10.008","article-title":"A review of dopamine agonist therapy in type 2 diabetes and effects on cardio-metabolic parameters","volume":"10","author":"EM Lamos","year":"2016","journal-title":"Prim Care Diabetes"},{"issue":"12","key":"pone.0320157.ref007","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.bcp.2010.01.029","article-title":"The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the \u03b12-adrenergic receptors in beta cells","volume":"79","author":"JE de Leeuw van Weenen","year":"2010","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"pone.0320157.ref008","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000054415","article-title":"Intracerebroventricular administration of bromocriptine ameliorates the insulin-resistant\/glucose-intolerant state in hamsters","volume":"69","author":"S Luo","year":"1999","journal-title":"Neuroendocrinology"},{"key":"pone.0320157.ref009","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1134\/S1607672914060027","article-title":"The influence of bromocryptine treatment on activity of the adenylyl cyclase system in the brain of rats with type 2 diabetes mellitus induced by high-fat diet","volume":"459","author":"AO Shpakov","year":"2014","journal-title":"Dokl Biochem Biophys"},{"issue":"4","key":"pone.0320157.ref010","doi-asserted-by":"crossref","first-page":"109040","DOI":"10.1016\/j.celrep.2021.109040","article-title":"A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome","volume":"35","author":"MJ Henderson","year":"2021","journal-title":"Cell Rep"},{"issue":"2","key":"pone.0320157.ref011","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1081\/CBI-100101040","article-title":"Association of the antidiabetic effects of bromocriptine with a shift in the daily rhythm of monoamine metabolism within the suprachiasmatic nuclei of the Syrian hamster","volume":"17","author":"S Luo","year":"2000","journal-title":"Chronobiol Int"},{"issue":"11","key":"pone.0320157.ref012","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.3390\/ijms22116142","article-title":"Time-of-day-dependent effects of bromocriptine to ameliorate vascular pathology and metabolic syndrome in SHR rats held on high fat diet","volume":"22","author":"M Ezrokhi","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pone.0320157.ref013","doi-asserted-by":"crossref","first-page":"E62","DOI":"10.1152\/ajpendo.00325.2019","article-title":"Bromocriptine improves glucose tolerance independent of circadian timing, prolactin, or the melanocortin-4 receptor","volume":"318","author":"SN Framnes-DeBoer","year":"2020","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"pone.0320157.ref014","doi-asserted-by":"crossref","first-page":"713418","DOI":"10.3389\/fphar.2021.713418","article-title":"Peripheral dopamine directly acts on insulin-sensitive tissues to regulate insulin signaling and metabolic function","volume":"12","author":"G Tavares","year":"2021","journal-title":"Front Pharmacol"},{"issue":"8","key":"pone.0320157.ref015","doi-asserted-by":"crossref","first-page":"104771","DOI":"10.1016\/j.isci.2022.104771","article-title":"Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptine","volume":"25","author":"D Aslanoglou","year":"2022","journal-title":"iScience"},{"issue":"8","key":"pone.0320157.ref016","doi-asserted-by":"crossref","first-page":"482","DOI":"10.5483\/BMBRep.2012.45.8.024","article-title":"Cyclosporine A and bromocriptine attenuate cell death mediated by intracellular calcium mobilization","volume":"45","author":"IK Kim","year":"2012","journal-title":"BMB Rep"},{"issue":"43","key":"pone.0320157.ref017","doi-asserted-by":"crossref","first-page":"21732","DOI":"10.1073\/pnas.1907288116","article-title":"Sustained ER stress promotes hyperglycemia by increasing glucagon action through the deubiquitinating enzyme USP14","volume":"116","author":"B Liu","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"pone.0320157.ref018","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3892\/or.2017.5676","article-title":"Fisetin inhibits liver cancer growth in a mouse model: relation to dopamine receptor","volume":"38","author":"X-F Liu","year":"2017","journal-title":"Oncol Rep"},{"issue":"11","key":"pone.0320157.ref019","doi-asserted-by":"crossref","first-page":"e374","DOI":"10.1371\/journal.pbio.0040374","article-title":"Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins","volume":"4","author":"DT Rutkowski","year":"2006","journal-title":"PLoS Biol"},{"issue":"3","key":"pone.0320157.ref020","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ncb0311-184","article-title":"Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress","volume":"13","author":"I Tabas","year":"2011","journal-title":"Nat Cell Biol"},{"issue":"3","key":"pone.0320157.ref021","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF00181955","article-title":"Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat","volume":"95","author":"JM Monti","year":"1988","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"pone.0320157.ref022","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.1365-2443.1996.d01-238.x","article-title":"Dopamine D2 receptor plays a critical role in cell proliferation and proopiomelanocortin expression in the pituitary","volume":"1","author":"H Yamaguchi","year":"1996","journal-title":"Genes Cells"},{"issue":"50","key":"pone.0320157.ref023","doi-asserted-by":"crossref","first-page":"13390","DOI":"10.1523\/JNEUROSCI.2680-08.2008","article-title":"Dopamine D1 receptor modulates hippocampal representation plasticity to spatial novelty","volume":"28","author":"AH Tran","year":"2008","journal-title":"J Neurosci"},{"issue":"1","key":"pone.0320157.ref024","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1210\/en.2015-1488","article-title":"Nighttime administration of nicotine improves hepatic glucose metabolism via the hypothalamic orexin system in mice","volume":"157","author":"H Tsuneki","year":"2016","journal-title":"Endocrinology"},{"issue":"1\u20132","key":"pone.0320157.ref025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0014-2999(94)90688-2","article-title":"On the mechanisms by which theophylline changes core body temperature in mice","volume":"257","author":"MR Zarrindast","year":"1994","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"pone.0320157.ref026","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s002130050321","article-title":"The influence of chronic treatment with clonidine, yohimbine and idazoxan on morphine withdrawal","volume":"132","author":"AO El-Kadi","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"pone.0320157.ref027","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1900\/RDS.2007.4.185","article-title":"Bromocriptine-induced hyperglycemia in nonobese diabetic mice: kinetics and mechanisms of action","volume":"4","author":"S Durant","year":"2007","journal-title":"Rev Diabet Stud"},{"key":"pone.0320157.ref028","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bbr.2014.01.032","article-title":"Time-dependent effects of prazosin on the development of methamphetamine conditioned hyperactivity and context-specific sensitization in mice","volume":"263","author":"AO White","year":"2014","journal-title":"Behav Brain Res"},{"issue":"1","key":"pone.0320157.ref029","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ajpath.2020.09.012","article-title":"Visualization of spatially-controlled vasospasm by sympathetic nerve-mediated ROCK activation","volume":"191","author":"A Imanishi","year":"2021","journal-title":"Am J Pathol"},{"issue":"3","key":"pone.0320157.ref030","first-page":"308","article-title":"Is the sympathoexcitatory effect of yohimbine determined by brain yohimbine concentration?","volume":"344","author":"YJ Kuo","year":"1991","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"10","key":"pone.0320157.ref031","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0024-3205(97)00599-7","article-title":"Bromocriptine\/SKF38393 treatment ameliorates obesity and associated metabolic dysfunctions in obese (ob\/ob) mice","volume":"61","author":"AH Cincotta","year":"1997","journal-title":"Life Sci"},{"issue":"1","key":"pone.0320157.ref032","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0006-8993(01)02455-6","article-title":"Reversal of reserpine-induced vacuous chewing movements in rats by melatonin: involvement of peripheral benzodiazepine receptors","volume":"904","author":"V Raghavendra","year":"2001","journal-title":"Brain Res"},{"issue":"2","key":"pone.0320157.ref033","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000170586","article-title":"Bromocriptine administration reduces hyperphagia and adiposity and differentially affects dopamine D2 receptor and transporter binding in leptin-receptor-deficient Zucker rats and rats with diet-induced obesity","volume":"89","author":"LM Davis","year":"2009","journal-title":"Neuroendocrinology"},{"issue":"3","key":"pone.0320157.ref034","doi-asserted-by":"crossref","first-page":"111497","DOI":"10.1016\/j.celrep.2022.111497","article-title":"Hypothalamic orexin prevents non-alcoholic steatohepatitis and hepatocellular carcinoma in obesity","volume":"41","author":"H Tsuneki","year":"2022","journal-title":"Cell Rep"},{"key":"pone.0320157.ref035","doi-asserted-by":"crossref","first-page":"1145769","DOI":"10.3389\/fgene.2023.1145769","article-title":"Hepatic gene expression profiles during fed-fasted-refed state in mice","author":"N Ji","year":"2023","journal-title":"Front Genet"},{"issue":"2","key":"pone.0320157.ref036","doi-asserted-by":"crossref","first-page":"265","DOI":"10.7150\/ijbs.3660","article-title":"Measurement of hepatic protein fractional synthetic rate with stable isotope labeling technique in thapsigargin stressed HepG2 cells","volume":"8","author":"J Song","year":"2012","journal-title":"Int J Biol Sci"},{"issue":"1","key":"pone.0320157.ref037","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12885-017-3153-4","article-title":"Cyproterone acetate enhances TRAIL-induced androgen-independent prostate cancer cell apoptosis via up-regulation of death receptor 5","volume":"17","author":"L Chen","year":"2017","journal-title":"BMC Cancer"},{"issue":"11","key":"pone.0320157.ref038","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/s42255-022-00673-y","article-title":"Food odor perception promotes systemic lipid utilization","volume":"4","author":"H Tsuneki","year":"2022","journal-title":"Nat Metab"},{"issue":"2","key":"pone.0320157.ref039","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2337\/db14-0695","article-title":"Hypothalamic orexin prevents hepatic insulin resistance via daily bidirectional regulation of autonomic nervous system in mice","volume":"64","author":"H Tsuneki","year":"2015","journal-title":"Diabetes"},{"issue":"1\u20133","key":"pone.0320157.ref040","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ejphar.2004.10.023","article-title":"Altered glucose homeostasis in \u03b12A-adrenoceptor knockout mice","volume":"505","author":"V Fagerholm","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"pone.0320157.ref041","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ejphar.2014.08.022","article-title":"Activation of spinal \u03b12 adrenergic receptors induces hyperglycemia in mouse though activating sympathetic outflow","volume":"741","author":"Y-B Sim","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"pone.0320157.ref042","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1758-5996-6-104","article-title":"Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats","volume":"6","author":"M Ezrokhi","year":"2014","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"pone.0320157.ref043","doi-asserted-by":"crossref","first-page":"E133","DOI":"10.1152\/ajpendo.00479.2019","article-title":"Bromocriptine mesylate improves glucose tolerance and disposal in a high-fat-fed canine model","volume":"319","author":"MC Moore","year":"2020","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6665","key":"pone.0320157.ref044","doi-asserted-by":"crossref","first-page":"eabl7398","DOI":"10.1126\/science.abl7398","article-title":"Integrative neurocircuits that control metabolism and food intake","volume":"381","author":"JC Br\u00fcning","year":"2023","journal-title":"Science"},{"key":"pone.0320157.ref045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pharmthera.2017.12.010","article-title":"Chronopathophysiological implications of orexin in sleep disturbances and lifestyle-related disorders","volume":"186","author":"H Tsuneki","year":"2018","journal-title":"Pharmacol Ther"},{"key":"pone.0320157.ref046","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3389\/fphar.2018.00771","article-title":"Novel trajectories of bromocriptine antidiabetic action: leptin-IL-6\/ JAK2\/p-STAT3\/SOCS3, p-IR\/p-AKT\/GLUT4, PPAR-\u03b3\/adiponectin, Nrf2\/PARP-1, and GLP-1","volume":"9","author":"E Reda","year":"2018","journal-title":"Front Pharmacol"},{"issue":"6","key":"pone.0320157.ref047","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.cell.2010.02.034","article-title":"Endoplasmic reticulum stress and the inflammatory basis of metabolic disease","volume":"140","author":"GS Hotamisligil","year":"2010","journal-title":"Cell"},{"issue":"10","key":"pone.0320157.ref048","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1007\/s00125-008-1094-9","article-title":"Chemical induction of the unfolded protein response in the liver increases glucose production and is activated during insulin-induced hypoglycaemia in rats","volume":"51","author":"JC Gonzales","year":"2008","journal-title":"Diabetologia"},{"issue":"6","key":"pone.0320157.ref049","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.tibs.2011.03.001","article-title":"Modulating stress responses by the UPRosome: a matter of life and death","volume":"36","author":"U Woehlbier","year":"2011","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"pone.0320157.ref050","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF03189581","article-title":"Fate and disposition of bromocriptine in animals and man. II: absorption, elimination and metabolism","volume":"8","author":"G Maurer","year":"1983","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"4","key":"pone.0320157.ref051","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/bcp.15660","article-title":"Dopamine agonists for the treatment of pituitary tumours: from ergot extracts to next generation therapies","volume":"89","author":"TL Wexler","year":"2023","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"pone.0320157.ref052","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ejps.2012.12.007","article-title":"Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model","volume":"48","author":"S Md","year":"2013","journal-title":"Eur J Pharm Sci"},{"issue":"10","key":"pone.0320157.ref053","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1096\/fasebj.12.10.905","article-title":"Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice","volume":"12","author":"D Muralikrishnan","year":"1998","journal-title":"FASEB J"},{"issue":"3","key":"pone.0320157.ref054","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1152\/physrev.00041.2006","article-title":"Physiology and neurobiology of stress and adaptation: central role of the brain","volume":"87","author":"BS McEwen","year":"2007","journal-title":"Physiol Rev"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0320157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T19:57:24Z","timestamp":1743019044000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0320157"}},"subtitle":[],"editor":[{"given":"Koh","family":"Ono","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":54,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0320157","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]}}}